PURCHASE, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CARCINOID CANCER FOUNDATION, founded in 1968, is a micro nonprofit in the Medical Research sector that reported $20K in total revenue in fiscal year 2025. Revenue fell 92% from the prior year — a significant decline worth monitoring. Expenses of $610K exceeded revenue, resulting in a 2945% operating deficit.
ORGANIZATION MISSION: TO PROVIDE EDUCATION AND AWARENESS INFORMATION TO PATIENTS AND FAMILIES OF PATIENTS IMPACTED BY CARCINOID AND NEUROENDOCRINE TUMORS, AS WELL AS TO SERVE AS ADVOCATES THROUGHOUT THE COMMUNITY CONNECTING PHYSICIANS, CAREGIVERS, PATIENTS, FAMILIES OF PATIENTS AND THOSE ORGANIZATIONS SERVING THE COMMUNITY WITH DIAGNOSTIC TOOLS AND METHODS AS WELL AS THOSE PROVIDING TREATMENT.
PROVIDES INFORMATION AND EDUCATION FOR MEDICAL PROFESSIONALS, PATIENTS, CAREGIVERS, AND THE GENERAL PUBLIC; PROVIDES E-MAIL AND TELEPHONE SUPPORT; WORKS TO IMPROVE ACCESS TO ACCURATE AND UP-TO-DATE...
PROVIDES INFORMATION AND EDUCATION FOR MEDICAL PROFESSIONALS, PATIENTS, CAREGIVERS, AND THE GENERAL PUBLIC; PROVIDES E-MAIL AND TELEPHONE SUPPORT; WORKS TO IMPROVE ACCESS TO ACCURATE AND UP-TO-DATE INFORMATION. DIGITAL OUTREACH NATIONALLY AND INTERNATIONALLY THROUGH CCF'S WEBSITE,E-NEWSLETTER, BLOG AND SOCIAL MEDIA CHANNELS, INCLUDING FACEBOOK, YOUTUBE AND TWITTER, REACHES OVER 400,000 PEOPLE ANNUALLY IN MORE THAN 150 COUNTRIES. ENCOURAGES AND SUPPORTS RESEARCH IN THE AREA OF CARCINOID AND NEUROENDOCRINE TUMORS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $20,019 | $253,199 | -0.9% |
| Expenses | $609,671 | $362,195 | +0.7% |
| Net Income | $-589,652 | $-108,996 | +4.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BRIAN THEDE | DIR/BOARD MEMBER | 0.25 |
Director
|
$0 | $0 | $0 |
| STEVEN MUELLER | DIRECTOR/BOARD MEMBE | 0.25 |
Director
|
$0 | $0 | $0 |
| KEITH WARNER | CEO/CHAIRMAN/TREASURER | 40.00 |
Officer
|
$157,833 | $0 | $157,833 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2026 | $20,019 | $609,671 | No data | $-589,652 |
| 2025 | $253,199 | $362,195 | $597,207 | $-108,996 |
| 2024 | $197,343 | $373,195 | $701,203 | $-175,852 |
| 2023 | $434,109 | $485,972 | $880,761 | $-51,863 |
| 2022 | $461,567 | $422,645 | $938,466 | $38,922 |
| 2021 | $405,113 | $502,219 | $889,113 | $-97,106 |
| 2020 | $504,363 | $456,577 | $985,604 | $47,786 |
| 2019 | $557,464 | $480,559 | $939,661 | $76,905 |
Compare CARCINOID CANCER FOUNDATION with other nonprofits in New York and across the country.